Who founded Belenos Biosciences?

Belenos Biosciences was founded by Donnie McGrath, Megan Dow, Tania Dimitrova, Glenn Rosen, Donnie McGrath, M.D., M.P.H., Megan Dow, Ph.D., Tania Dimitrova, M.B.A in 2024.

Who are Belenos Biosciences's investors?

Belenos Biosciences's investors include OrbiMed.

How much funding has Belenos Biosciences raised?

Belenos Biosciences has disclosed $48M raised across 1 round.

Where is Belenos Biosciences headquartered?

Belenos Biosciences is headquartered in New York, US.

Belenos Biosciences

New York, US · Founded 2024 · 1 known investors

Find your way into Belenos Biosciences

Paths you didn't know you had: your email and LinkedIn already hold routes to the Belenos Biosciences team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Belenos Biosciences develops long-acting bispecific antibody therapeutics for chronic inflammatory diseases such as COPD, asthma, atopic dermatitis, CRSwNP, and CSU. Its pipeline includes BEL512 (targeting TSLP and IL-13) and BEL536 (targeting OX40L and IL-13), both aimed at modulating type 2 inflammation.

Biotech Healthtech

Founders & leadership

Donnie McGrathCEO & Co-Founder

Megan DowCOO & Co-Founder

Tania DimitrovaCFO & Co-Founder

Glenn RosenChief Translational Officer & Co-Founder

Donnie McGrath, M.D., M.P.H.CEO & Co-FounderA physician-executive who has worked across drug development, corporate strategy, and business development, he served as Chief Corporate Strategy and Business Development officer at Biohaven and as CEO and later President and Executive Chairman of its China-focused affiliate BioShin. Earlier, he spent nearly a decade at Bristol-Myers Squibb in roles including development lead and Global Head of Virology and Neuroscience Search and Evaluation, and he has been a venture partner at OrbiMed since 2023.

Megan Dow, Ph.D.COO & Co-Founder

Tania Dimitrova, M.B.ACFO & Co-Founder

StJohn Donnie McGrathExecutive

Board

Bo ChenBoard director

Carl Gordon Board directorManaging Partner at OrbiMed

David Wang Board directorPartner at OrbiMed

Investors · 1

OrbiMedlisted by OrbiMedNew York · $1M – $75M

How we know: OrbiMed's portfolio page · board seat on SEC Form D · the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$48M disclosed across 1 round · 2024

▶$48MraisedJul 2024 · 2 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Bo ChenDirector
Carl GordonDirector
Tania DimitrovaExecutive Officer
David WangDirector
Megan DowExecutive Officer
StJohn Donnie McGrathExecutive Officer, Director

Offering amount: $55M
Amount sold: $48M
First sale: Jul 2024
Incorporated: Corporation, Delaware, 2024
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Belenos Biosciences do?: Belenos Biosciences develops long-acting bispecific antibody therapeutics for chronic inflammatory diseases such as COPD, asthma, atopic dermatitis, CRSwNP, and CSU. Its pipeline includes BEL512 (targeting TSLP and IL-13) and BEL536 (targeting OX40L and IL-13), both aimed at modulating type 2 inflammation.
Who founded Belenos Biosciences?: Belenos Biosciences was founded by Donnie McGrath, Megan Dow, Tania Dimitrova, Glenn Rosen, Donnie McGrath, M.D., M.P.H., Megan Dow, Ph.D., Tania Dimitrova, M.B.A in 2024.
Who are Belenos Biosciences's investors?: Belenos Biosciences's investors include OrbiMed.
How much funding has Belenos Biosciences raised?: Belenos Biosciences has disclosed $48M raised across 1 round.
Where is Belenos Biosciences headquartered?: Belenos Biosciences is headquartered in New York, US.